ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 69 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $18 | -99.8% | 34,141 | +134.6% | 0.00% | – |
| Q3 2022 | $11,000 | -45.0% | 14,553 | -18.8% | 0.00% | – |
| Q2 2022 | $20,000 | -60.8% | 17,929 | -27.5% | 0.00% | -100.0% |
| Q1 2022 | $51,000 | -62.8% | 24,725 | -48.1% | 0.00% | 0.0% |
| Q4 2021 | $137,000 | +38.4% | 47,659 | +103.1% | 0.00% | 0.0% |
| Q3 2021 | $99,000 | -57.7% | 23,466 | -46.8% | 0.00% | -66.7% |
| Q2 2021 | $234,000 | +178.6% | 44,147 | +144.6% | 0.00% | +200.0% |
| Q1 2021 | $84,000 | -85.0% | 18,047 | -89.1% | 0.00% | -93.3% |
| Q2 2020 | $559,000 | +598.8% | 165,731 | +1147.0% | 0.02% | +650.0% |
| Q4 2019 | $80,000 | – | 13,290 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 507,191 | $5,107,000 | 0.50% |
| Cormorant Asset Management, LP | 356,600 | $3,591,000 | 0.43% |
| Perceptive Advisors | 558,446 | $5,623,000 | 0.42% |
| NEXTHERA CAPITAL LP | 15,000 | $151,000 | 0.21% |
| EMERALD ADVISERS, LLC | 237,070 | $2,387,000 | 0.11% |
| AUXIER ASSET MANAGEMENT | 17,857 | $180,000 | 0.04% |
| FEDERATED HERMES, INC. | 450,000 | $4,532,000 | 0.01% |
| Nationwide Fund Advisors | 49,473 | $498,000 | 0.00% |
| Catalyst Capital Advisors LLC | 348 | $4,000 | 0.00% |
| DEUTSCHE BANK AG\ | 859 | $8,000 | 0.00% |